Veeva Systems [VEEV] vs Doximity [DOCS] Detailed Stock Comparison

Veeva Systems

Doximity
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Veeva Systems wins in 10 metrics, Doximity wins in 9 metrics, with 0 ties. Veeva Systems appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Veeva Systems | Doximity | Better |
---|---|---|---|
P/E Ratio (TTM) | 58.89 | 63.66 | Veeva Systems |
Price-to-Book Ratio | 7.24 | 13.73 | Veeva Systems |
Debt-to-Equity Ratio | 1.29 | 1.16 | Doximity |
PEG Ratio | 3.67 | 2.33 | Doximity |
EV/EBITDA | 48.87 | 54.29 | Veeva Systems |
Profit Margin (TTM) | 27.29% | 39.88% | Doximity |
Operating Margin (TTM) | 28.71% | 37.48% | Doximity |
EBITDA Margin (TTM) | 28.71% | 37.48% | Doximity |
Return on Equity | 13.70% | 24.25% | Doximity |
Return on Assets (TTM) | 7.24% | 13.13% | Doximity |
Free Cash Flow (TTM) | $1.09B | $266.74M | Veeva Systems |
1-Year Return | 46.96% | 66.89% | Doximity |
Price-to-Sales Ratio (TTM) | 16.19 | 23.63 | Veeva Systems |
Enterprise Value | $42.51B | $13.24B | Veeva Systems |
EV/Revenue Ratio | 14.32 | 22.46 | Veeva Systems |
Gross Profit Margin (TTM) | 75.26% | 89.18% | Doximity |
Revenue per Share (TTM) | $18 | $3 | Veeva Systems |
Earnings per Share (Diluted) | $4.98 | $1.18 | Veeva Systems |
Beta (Stock Volatility) | 0.95 | 1.37 | Veeva Systems |
Veeva Systems vs Doximity Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Veeva Systems | 2.57% | 7.45% | 11.41% | 6.43% | 32.78% | 42.84% |
Doximity | 1.91% | -3.21% | 7.45% | 21.38% | 24.23% | 34.41% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Veeva Systems | 46.96% | 81.38% | 2.27% | 1,066.76% | 577.61% | 577.61% |
Doximity | 66.89% | 146.55% | 30.67% | 30.67% | 30.67% | 30.67% |
News Based Sentiment: Veeva Systems vs Doximity
Veeva Systems
News based Sentiment: POSITIVE
Veeva demonstrated strong financial results and continued expansion of its CRM platform within the biopharma industry, despite a minor stock decline. The upcoming Investor Day presents an opportunity for management to articulate their vision and reinforce investor confidence.
Doximity
News based Sentiment: MIXED
October brought a mix of positive financial projections and concerning signals for Doximity. While the company is expected to continue growing revenue and earnings, a downgrade from Goldman Sachs, significant insider selling, and potential regulatory risks create uncertainty. This combination of factors makes October a significant month for investors to reassess their positions.
Performance & Financial Health Analysis: Veeva Systems vs Doximity
Metric | VEEV | DOCS |
---|---|---|
Market Information | ||
Market Cap | $48.07B | $14.07B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 1,264,800 | 1,577,510 |
90 Day Avg. Volume | 1,442,037 | 1,326,787 |
Last Close | $300.79 | $71.99 |
52 Week Range | $200.30 - $300.88 | $40.87 - $85.21 |
% from 52W High | -0.03% | -15.51% |
All-Time High | $343.96 (Aug 02, 2021) | $107.79 (Sep 06, 2021) |
% from All-Time High | -12.55% | -33.21% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.17% | 0.15% |
Quarterly Earnings Growth | 0.17% | 0.29% |
Financial Health | ||
Profit Margin (TTM) | 0.27% | 0.40% |
Operating Margin (TTM) | 0.29% | 0.37% |
Return on Equity (TTM) | 0.14% | 0.24% |
Debt to Equity (MRQ) | 1.29 | 1.16 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $40.51 | $5.47 |
Cash per Share (MRQ) | $39.07 | $4.49 |
Operating Cash Flow (TTM) | $1.35B | $294.12M |
Levered Free Cash Flow (TTM) | $1.10B | $231.29M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Veeva Systems vs Doximity
Metric | VEEV | DOCS |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 58.89 | 63.66 |
Forward P/E | 43.38 | 63.13 |
PEG Ratio | 3.67 | 2.33 |
Price to Sales (TTM) | 16.19 | 23.63 |
Price to Book (MRQ) | 7.24 | 13.73 |
Market Capitalization | ||
Market Capitalization | $48.07B | $14.07B |
Enterprise Value | $42.51B | $13.24B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 14.32 | 22.46 |
Enterprise to EBITDA | 48.87 | 54.29 |
Risk & Other Metrics | ||
Beta | 0.95 | 1.37 |
Book Value per Share (MRQ) | $40.51 | $5.47 |
Financial Statements Comparison: Veeva Systems vs Doximity
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | VEEV | DOCS |
---|---|---|
Revenue/Sales | $759.04M | $145.91M |
Cost of Goods Sold | $173.82M | $15.79M |
Gross Profit | $585.22M | $130.12M |
Research & Development | $184.03M | $26.80M |
Operating Income (EBIT) | $233.73M | $54.52M |
EBITDA | $243.55M | $57.31M |
Pre-Tax Income | $298.82M | $64.15M |
Income Tax | $70.63M | $10.83M |
Net Income (Profit) | $228.19M | $53.32M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | VEEV | DOCS |
---|---|---|
Cash & Equivalents | $1.96B | $209.61M |
Total Current Assets | $6.71B | $1.09B |
Total Current Liabilities | $1.46B | $156.26M |
Long-Term Debt | $66.57M | $10.19M |
Total Shareholders Equity | $6.21B | $1.08B |
Retained Earnings | $3.68B | $186.89M |
Property, Plant & Equipment | $122.23M | $8.89M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | VEEV | DOCS |
---|---|---|
Operating Cash Flow | $810.54M | $119.90M |
Capital Expenditures | N/A | $0 |
Free Cash Flow | $877.16M | $96.98M |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | $-26.79M |
Short Interest & Institutional Ownership Analysis
Metric | VEEV | DOCS |
---|---|---|
Shares Short | 5.41M | 4.82M |
Short Ratio | 3.60 | 3.93 |
Short % of Float | 0.04% | 0.04% |
Average Daily Volume (10 Day) | 1,264,800 | 1,577,510 |
Average Daily Volume (90 Day) | 1,442,037 | 1,326,787 |
Shares Outstanding | 162.58M | 188.88M |
Float Shares | 150.41M | 133.22M |
% Held by Insiders | 0.09% | 0.02% |
% Held by Institutions | 0.89% | 0.91% |
Dividend Analysis & Yield Comparison: Veeva Systems vs Doximity
Metric | VEEV | DOCS |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |